Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Ketorolac for Inflammatory Hand and Upper Extremity Disorders
NCT02266433Phase 3Terminated
- Sponsor
- NYU Langone Health
- Start
- Aug 2012
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac in de Quervain's tenosynovitis, trigger finger and Lateral Epicondylitis (LET), sponsored by NYU Langone Health. Primary endpoint: Quick Disabilities of the Arm, Shoulder and Hand at 6 months. Started Aug 2012; status: terminated.
02
Drugs
ketorolac
03
Conditions
de Quervain's tenosynovitistrigger fingerLateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT02266433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266433.